Musclepharm Corporation

4400 Vanowen Street

Burbank, CA 91505

(303) 396-6100

January 10, 2018

BY EDGAR

Securities and Exchange CommissionOffice of Global Security Risk

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Cecilia Blye

Re:    

Comment Letter Dated December 22, 2017

Musclepharm Corporation

Form 10-K for Fiscal Year Ended December 31, 2016

File No. 0-53166

Dear Ms. Blye:

Musclepharm Corporation (the “Company”) hereby submits a request for an extension to respond to the comment letter referenced above until January 22, 2018. Due to reduced resources available at the Company during the recent holiday break, the Company will require additional time to prepare its response.

If you have any questions relating to the foregoing, please contact the undersigned at (818) 658-3806.

Sincerely,

Musclepharm Corporation

By: /s/ Kevin Harris                             

Name: Kevin Harris

Title: Interim Chief Financial Officer